1. Synthesis of Nd2Fe14C compound by high-energy ball-milling Nd–Fe alloy in heptane and annealing under vacuum. (3rd May 2016) Authors: Geng, H M; Ji, Y; Feng, X Y; Zhang, J J; Ran, Z; Yan, Y; Wang, W Q; Su, F; Du, X B Journal: Journal of physics Issue: Volume 49:Number 21(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P672 Drug therapy and monitoring for inflammatory bowel diseases: preliminary data from a multi-centre investigation in Asia. (25th January 2019) Authors: Cai, C; Shen, J; Tong, J; Lu, J; Zheng, Q; Wu, K; Qian, J; Ran, Z Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. (July 2022) Authors: Ananthakrishnan, Ashwin N; Kaplan, Gilaad G; Bernstein, Charles N; Burke, Kristin E; Lochhead, Paul J; Sasson, Alexa N; Agrawal, Manasi; Tiong, Jimmy Ho Tuan; Steinberg, Joshua; Kruis, Wolfgang; Steinwurz, Flavio; Ahuja, Vineet; Ng, Siew C; Rubin, David T; Colombel, Jean-Frederic; Gearry, Richard... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 7(2022) Page Start: 666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP36 Risankizumab therapy induces improvements in endoscopic endpoints in patients with Moderate-to-Severe Crohn's Disease: Results from the phase 3 ADVANCE and MOTIVATE studies. (27th May 2021) Authors: Bossuyt, P; Ferrante, M; Baert, F; Danese, S; Feagan, B G; Loftus Jr, E V; Panés, J; Peyrin-Biroulet, L; Ran, Z; Armuzzi, A; D'Haens, G R; Song, A; Neimark, E; Liao, X; Zhou, Q; Berg, S; Wallace, K; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP01 Efficacy and safety of the IL-6 trans-signalling inhibitor olamkicept: a phase 2 randomized, placebo-controlled trial in moderately to severely active Ulcerative Colitis. (27th May 2021) Authors: Chen, B; Zhang, S; Wang, B; Chen, H; Li, Y; Cao, Q; Zhong, J; Xie, M; Ran, Z; Tang, T; Yang, M; Guo, T; Xu, B; Cai, Z; Schreiber, S; Chen, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P340 Issues on implementing treat-to-target approach in Asia Pacific, Middle East and Africa: Reality, gaps, and way forward -APMA IBD Coalition. (30th January 2023) Authors: Akyüz, F; An, Y K; Aniwan, S; Bui, H H; Chan, W P; Choi, C H; Chopdat, N; Connor, S; Desai, D; Flanagan, E; Kobayashi, T; Leong, R W; Leow, A; Leung, W K; Limsrivilai, J; Peddi, K; Pribadi, R R; Ran, Z; Wei, S C; Wu, K Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗